Fricker D - Search Results

1

Novel human pathological mutations. Gene symbol: TAP2. Disease: HLA class I deficiency.

de la Salle H, Fricker D, Hanau D, Dogu F, Ikinciogullari A. de la Salle H, et al. Among authors: fricker d. Hum Genet. 2007 Jun;121(5):646-7. Hum Genet. 2007. PMID: 17879436 No abstract available.

2

Novel human pathological mutations. Gene symbol: TAP2. Disease: HLA class I deficiency.

de la Salle H, Fricker D, Hanau D, Langguth D, Hogan P. de la Salle H, et al. Among authors: fricker d. Hum Genet. 2007 Jun;121(5):651. Hum Genet. 2007. PMID: 17879452 No abstract available.

3

Homozygous human TAP peptide transporter mutation in HLA class I deficiency.

de la Salle H, Hanau D, Fricker D, Urlacher A, Kelly A, Salamero J, Powis SH, Donato L, Bausinger H, Laforet M, et al. de la Salle H, et al. Among authors: fricker d. Science. 1994 Jul 8;265(5169):237-41. doi: 10.1126/science.7517574. Science. 1994. PMID: 7517574

4

CD1 expression is not affected by human peptide transporter deficiency.

Hanau D, Fricker D, Bieber T, Esposito-Farese ME, Bausinger H, Cazenave JP, Donato L, Tongio MM, de la Salle H. Hanau D, et al. Among authors: fricker d. Hum Immunol. 1994 Sep;41(1):61-8. doi: 10.1016/0198-8859(94)90086-8. Hum Immunol. 1994. PMID: 7530699

5

Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens.

de la Salle H, Houssaint E, Peyrat MA, Arnold D, Salamero J, Pinczon D, Stevanovic S, Bausinger H, Fricker D, Gomard E, Biddison W, Lehner P, UytdeHaag F, Sasportes M, Donato L, Rammensee HG, Cazenave JP, Hanau D, Tongio MM, Bonneville M. de la Salle H, et al. Among authors: fricker d. J Immunol. 1997 May 15;158(10):4555-63. J Immunol. 1997. PMID: 9144467

6

HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1.

de la Salle H, Zimmer J, Fricker D, Angenieux C, Cazenave JP, Okubo M, Maeda H, Plebani A, Tongio MM, Dormoy A, Hanau D. de la Salle H, et al. Among authors: fricker d. J Clin Invest. 1999 Mar;103(5):R9-R13. doi: 10.1172/JCI5687. J Clin Invest. 1999. PMID: 10074495 Free PMC article.

7

Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP).

de la Salle H, Saulquin X, Mansour I, Klayme S, Fricker D, Zimmer J, Cazenave JP, Hanau D, Bonneville M, Houssaint E, Lefranc G, Naman R. de la Salle H, et al. Among authors: fricker d. Clin Exp Immunol. 2002 Jun;128(3):525-31. doi: 10.1046/j.1365-2249.2002.01862.x. Clin Exp Immunol. 2002. PMID: 12067308 Free PMC article.

8

Common characteristics of the human and rhesus macaque CD1e molecules: conservation of biochemical and biological properties during primate evolution.

Angénieux C, Salamero J, Fricker D, Wurtz JM, Maître B, Cazenave JP, Hanau D, de la Salle H. Angénieux C, et al. Among authors: fricker d. Immunogenetics. 2003 Mar;54(12):842-9. doi: 10.1007/s00251-003-0538-0. Epub 2003 Feb 21. Immunogenetics. 2003. PMID: 12671734

9

HLA class I deficiency syndrome mimicking Wegener's granulomatosis.

Villa-Forte A, de la Salle H, Fricker D, Hentges F, Zimmer J. Villa-Forte A, et al. Among authors: fricker d. Arthritis Rheum. 2008 Aug;58(8):2579-82. doi: 10.1002/art.23675. Arthritis Rheum. 2008. PMID: 18668571 Free article.

10

HLA-DQA2 and HLA-DQB2 genes are specifically expressed in human Langerhans cells and encode a new HLA class II molecule.

Lenormand C, Bausinger H, Gross F, Signorino-Gelo F, Koch S, Peressin M, Fricker D, Cazenave JP, Bieber T, Hanau D, de la Salle H, Tourne S. Lenormand C, et al. Among authors: fricker d. J Immunol. 2012 Apr 15;188(8):3903-11. doi: 10.4049/jimmunol.1103048. Epub 2012 Mar 9. J Immunol. 2012. PMID: 22407913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters